Hospital Universitario de La Ribera

Alzira, Valencia 46600

1 studies enrolling now · 3 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Obesity, Overweight, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Running, not enrolling
• A Study of LY3209590 in Participants With Type 1 Diabetes — Completed